Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS5 | Q9UNA0 | 20/20 | 0.86 |
| ▸ | MMP13 | P45452 | 3/20 | 0.86 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.85 |
| ▸ | ADAM17 | P78536 | 7/20 | 0.83 |
| ▸ | MMP2 | P08253 | 3/20 | 0.80 |
| ▸ | MMP14 | P50281 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20708255 | 0.95 | ADAMTS5 (0.90) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL17871295 | 0.93 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL19691675 | 0.92 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL17871335 | 0.91 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL17871553 | 0.90 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL17871153 | 0.89 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL20708334 | 0.89 | ADAMTS5 (0.73) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL17871342 | 0.87 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL20708598 | 0.87 | ADAMTS5 (0.87) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 | |
| SCHEMBL17871151 | 0.87 | ADAMTS5 (1.00) | ADAMTS5MMP13ADAMTS4ADAM17MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3237406-B1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2019-02-06 | — | — | EP | disclosed |